Postoperatory Venous Thromboembolism: A Serious Preventable Risk
Abstract
Postoperative deep venous thrombosis and pulmonary thromboembolism are complications which have incidence on morbimortality. Many researches evidence their figures and how thromboprophylaxis can reduce these risks. Different drugs and their level of protection have been evaluated, but the adherence to the published clinical practice guidelines is not optimal because of the lack of clarity in the management of patients with intermediate risk factors. The proved prevention with thromboprophylaxis forces to implement strategies to detect the patients at risk and to follow the guidelines.
References
2. Kakkar AK, Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ, Deslandes B. Venous Thromboembolism Risk and Prophylaxis in the Acute Care Hospital Setting. Ann Surg. 2010; (251): 3308.
3. Motte S, Samama CM, Guay J, Barre J, Borg JY. Prevention of Postoperative Venous Thromboembolism. Risk Assessment and Methods of Prophylaxis. Can J Anesth. 2006; (53): S68S79.
4. Sweetland S, Green J, Liu B, Berrington A, Canonico M, Reeves G. Duration and Magnitude of The Postoperative Risk of Venous Thromboembolism in Middle Aged Women: Prospective Cohort Study. BMJ. 2009; (339): b4583. Doi: 10.1136/bmj.b4583.
5. Michota FA. Prevention of Venous Thromboembolism after Surgery. Clev Clin J Med. 2009; (76), Suppl. 4: S45S52.
6. Mantilla C, Horlocker TT, Schroeder DR, Berry DJ. Risk Factors for Clinically Relevant Pulmonary Embolism and Deep Venous Thrombosis in Patients Undergoing Primary Hip or Knee Arthroplasty. Anesthesiology. 2003; (99): 55260.
7. Turpie AG, Lassen MR, Davidson BL. Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty: a Randomised Trial. Lancet. 2009; (373): 167380.
8. Eriksson BI, Borris LC, Friedman RJ. Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty. N Engl J Med. 2008; (358): 276575.
9. Lumpkin M. FDA Public Health Advisory. Anesthesiology. 1998; (88): 27A-8A.
10. Eikelboom JW, Quinlan DJ, Douketis JD. Extended Duration Prophylaxis against Venous Thromboembolism after Total Hip or Knee Replacement: a MetaAnalysis of the Randomized Trials. Lancet; 2001; (358): 915.
11. Bergqvist D, Agnelli G, Cohen AT. Duration of Prophylaxis against Venous Thromboembolism with Enoxaparin after Surgery for Cancer. N Engl J Med. 2002; (346): 97580.
12. Strebel N, Prins M, Agnelli G, Büller HR. Preoperativeor Postoperative Start of Prophylaxis for Venous Thromboembolismwith LowMolecularWeight Heparin Inelective Hip Surgery? Arch Intern Med, 2002; 162: 14516.
13. American Academy of Orthopedic Surgeons. Clinical Guideline on Prevention of Symptomatic Pulmonary Embolism in Patients undergoing Total Hip or Knee Arthroplasty. Available from http://www.aaos.org/Research/guidelines/PE_guideline.pdf. released may, 2007. Last accessed: April 19, 2010.
Downloads
Altmetric
Article metrics | |
---|---|
Abstract views | |
Galley vies | |
PDF Views | |
HTML views | |
Other views |